Shadow
07-14-2012, 12:06 PM
I really miss this stuff. My daughter and I swear that it is the only thing that cures migraines outside of gong to the doctor for a shot.
It's been half a year since Novartis voluntarily recalled certain packages of Excedrin (http://www.huffingtonpost.com/2012/01/09/excedrin-recall_n_1193996.html), NoDoz, Bufferin and Gas-X Prevention over stray or chipped pills, but the popular medicines are not yet back on store shelves.
Novartis, the manufacturer of the medicines, explained the status of the medicines in a statement:
We are working hard to return products to store shelves as soon as possible. Novartis Consumer Health will restart production on a line-by-line, product-by-product basis to ensure control and adherence to our high standard of quality and expects to begin shipments of a limited portfolio of products in the second half of the year. We are currently in the very early stages of validating our manufacturing processes.
In January of this year, the Food and Drug Administration announced that the recall affects Excedrin and NoDoz medicines with expiration dates of Dec. 20, 2014 or earlier and Bufferin and Gas-X Prevention medicines with expiration dates of Dec. 20, 2013 or earlier.
Novartis said that there were no reported adverse health events linked with the recalled medicines; it was a precautionary recall.
http://www.huffingtonpost.com/2012/07/11/excedrin-recall-migraine-medicine-novartis_n_1664974.html
It's been half a year since Novartis voluntarily recalled certain packages of Excedrin (http://www.huffingtonpost.com/2012/01/09/excedrin-recall_n_1193996.html), NoDoz, Bufferin and Gas-X Prevention over stray or chipped pills, but the popular medicines are not yet back on store shelves.
Novartis, the manufacturer of the medicines, explained the status of the medicines in a statement:
We are working hard to return products to store shelves as soon as possible. Novartis Consumer Health will restart production on a line-by-line, product-by-product basis to ensure control and adherence to our high standard of quality and expects to begin shipments of a limited portfolio of products in the second half of the year. We are currently in the very early stages of validating our manufacturing processes.
In January of this year, the Food and Drug Administration announced that the recall affects Excedrin and NoDoz medicines with expiration dates of Dec. 20, 2014 or earlier and Bufferin and Gas-X Prevention medicines with expiration dates of Dec. 20, 2013 or earlier.
Novartis said that there were no reported adverse health events linked with the recalled medicines; it was a precautionary recall.
http://www.huffingtonpost.com/2012/07/11/excedrin-recall-migraine-medicine-novartis_n_1664974.html